Medicare Enrolled
Dr. Richard McDonough, M.D.
Hematology & Oncology · Zephyrhills, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. McDonough from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McDonough? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. McDonough
Dr. Richard McDonough is a hematology & oncology in Zephyrhills, FL, with 20 years in practice. Based on federal Medicare data, Dr. McDonough performed 50,309 Medicare services across 1,909 unique beneficiaries.
Between the years covered by Open Payments, Dr. McDonough received a total of $364,047 from 93 pharmaceutical and/or device companies across 1122 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. McDonough is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 16% volume in FL$ $364,047 industry payments
Medicare Practice Summary
Medicare Utilization ↗50,309
Medicare services
Top 16% in FL for hematology & oncology
1,909
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,515 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 12,240 | $0 | $4 |
| Anti-nausea injection (aprepitant) | 11,050 | $1 | $5 |
| Iron sucrose injection (Venofer) | 7,800 | $0 | $5 |
| Denosumab injection (Prolia/Xgeva) | 4,560 | $19 | $51 |
| Epoetin alfa injection (Procrit) for anemia | 3,650 | $6 | $23 |
| Iron infusion (Monoferric) | 3,000 | $17 | $57 |
| Dexamethasone injection (steroid) | 1,522 | $0 | $3 |
| Complete blood count (CBC) with differential | 1,125 | $8 | $29 |
| Blood draw (venipuncture) | 1,068 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 920 | $1 | $28 |
| Office visit, established patient (30-39 min) | 738 | $92 | $339 |
| Drug injection, under skin or into muscle | 442 | $10 | $69 |
| Office visit, established patient (20-29 min) | 377 | $66 | $239 |
| Administration of chemotherapy into vein, 1 hour or less | 247 | $96 | $378 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 243 | $21 | $84 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 187 | $47 | $189 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 161 | $1 | $6 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 144 | $15 | $56 |
| Injection of additional new drug or substance into vein | 136 | $12 | $61 |
| Infusion into a vein for hydration, each additional hour | 91 | $10 | $42 |
| New patient office visit (45-59 min) | 91 | $124 | $453 |
| Administration of additional new drug or substance into vein, 1 hour or less | 90 | $48 | $178 |
| Infusion, normal saline solution , 1000 cc | 74 | $2 | $7 |
| Administration of chemotherapy into vein, each additional hour | 66 | $20 | $79 |
| Hospital follow-up visit, moderate complexity | 63 | $63 | $197 |
| Injection, diphenhydramine hcl, up to 50 mg | 59 | $1 | $3 |
| Red blood count, automated test | 42 | $4 | $10 |
| Infusion into a vein for hydration, 31-60 minutes | 34 | $24 | $156 |
| Initial hospital admission, moderate complexity | 32 | $103 | $377 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 28 | $22 | $89 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 15 | $1 | $7 |
| Office visit, established patient, complex (40-54 min) | 14 | $130 | $474 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
31.9% high complexity
60.9% medium
7.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$364,047
Total received (2018-2024)
Avg $52,007/year across 7 years
Top 4% in FL for hematology & oncology
93
Companies
1,122
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$183,077 (50.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$166,610 (45.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,360 (3.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$33,614
2023$28,588
2022$66,714
2021$80,014
2020$31,994
2019$99,787
2018$23,336
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Rigel Pharmaceuticals, Inc.
$260,030
BeiGene USA, Inc.
$79,842
Bayer HealthCare Pharmaceuticals Inc.
$3,690
Celgene Corporation
$3,649
Janssen Biotech, Inc.
$3,184
Novartis Pharmaceuticals Corporation
$1,218
AstraZeneca Pharmaceuticals LP
$821
PFIZER INC.
$774
Genentech USA, Inc.
$704
Seagen Inc.
$665
Eisai Inc.
$579
Merck Sharp & Dohme LLC
$536
E.R. Squibb & Sons, L.L.C.
$496
Astellas Pharma US Inc
$491
Merck Sharp & Dohme Corporation
$448
Lilly USA, LLC
$441
Gilead Sciences, Inc.
$419
GENZYME CORPORATION
$347
Incyte Corporation
$325
Pharmacyclics LLC, An AbbVie Company
$272
ABBVIE INC.
$242
Regeneron Healthcare Solutions, Inc.
$233
Daiichi Sankyo Inc.
$213
Takeda Pharmaceuticals U.S.A., Inc.
$210
EISAI INC.
$198
Exelixis Inc.
$195
Mirati Therapeutics, Inc.
$182
Amgen Inc.
$172
Boehringer Ingelheim Pharmaceuticals, Inc.
$163
Coherus Biosciences Inc.
$159
EMD Serono, Inc.
$150
Karyopharm Therapeutics Inc.
$147
Bayer Healthcare Pharmaceuticals Inc.
$140
JAZZ PHARMACEUTICALS INC.
$139
GlaxoSmithKline, LLC.
$122
Kite Pharma, Inc.
$122
CTI BioPharma Corp.
$107
TAIHO ONCOLOGY, INC.
$106
Helsinn Therapeutics (U.S.), Inc.
$106
Taiho Oncology, Inc.
$92
CSL Behring
$88
ARRAY BIOPHARMA INC
$85
Myovant Sciences Inc.
$80
Ipsen Biopharmaceuticals, Inc
$79
TerSera Therapeutics LLC
$70
Pharmacosmos Therapeutics Inc.
$69
Janssen Pharmaceuticals, Inc
$66
Seattle Genetics, Inc.
$66
PUMA BIOTECHNOLOGY, INC.
$66
Agios Pharmaceuticals, Inc.
$65
Stemline Therapeutics Inc.
$65
Dova Pharmaceuticals
$61
SOBI, INC
$58
Tempus AI, Inc
$52
Alexion Pharmaceuticals, Inc.
$50
Foundation Medicine, Inc.
$47
Pharmacyclics LLC, an AbbVie Company
$44
Sumitomo Pharma America, Inc.
$44
G1 Therapeutics, Inc.
$39
RECORDATI_RARE_DISEASES_INC.
$37
Alnylam Pharmaceuticals Inc.
$36
GE HEALTHCARE
$33
Blue Earth Diagnostics Limited
$31
Deciphera Pharmaceuticals Inc.
$31
Blueprint Medicines Corporation
$31
Novocure Inc.
$28
GE HealthCare
$28
Adaptive Biotechnologies Corporation
$27
Aveo Pharmaceuticals, Inc.
$25
Fennec Pharmaceuticals, Inc.
$25
AVEO Pharmaceuticals, Inc.
$22
MorphoSys, US Inc.
$22
PharmaEssentia USA Corporation
$21
AMAG Pharmaceuticals, Inc.
$20
Mylan Institutional Inc.
$20
Telix Pharmaceuticals
$19
SERVIER PHARMACEUTICALS LLC
$19
Myriad Genetic Laboratories, Inc.
$19
EUSA Pharma (US) LLC
$18
Emmaus Medical, Inc.
$18
TESARO, Inc.
$18
Sun Pharmaceutical Industries Inc.
$17
Acrotech Biopharma LLC
$17
NOVARTIS PHARMACEUTICALS CORPORATION
$16
Jazz Pharmaceuticals Inc.
$15
Spectrum Pharmaceuticals Inc.
$15
West Therapeutics Development, LLC
$15
Puma Biotechnology, Inc.
$15
INSYS Therapeutics Inc
$14
Partner Therapeutics, Inc.
$14
Dendreon Pharmaceuticals LLC
$14
Teva Pharmaceuticals USA, Inc.
$13
Verastem, Inc.
$11
Top 3 companies account for 94.4% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALOXI · ALUNBRIG · AUGTYRO · AYVAKIT · Abraxane · Afstyla · Alecensa · Aliqopa · Avastin · Axumin · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CARBAGLU · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · Doptelet · ELIQUIS · EMEND · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Endari · Enhertu · Erleada · FASLODEX · FERAHEME · FOTIVDA · FRUZAQLA · Fabhalta · Fulphila · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · Halaven · IBRANCE · ICLUSIG · ILLUCCIX · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Idelvion · Imbruvica · Inrebic · Itovebi · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · LIBTAYO · LONSURF · LOQTORZI · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lazanda · Lenvima · Leukine · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MYRISK · Monoferric · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · Optune Lua (NovoTTF-200T) · Orserdu · PADCEV · PANHEMATIN · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · Padcev · Pedmark · Perjeta · Phesgo · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · ROLVEDON · Revlimid · Rezlidhia · SARCLISA · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · SYNDROS · Somatuline Depot · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · Venclexta · Vitrakvi · Vonjo · Vyloy · XALKORI · XARELTO · XPOVIO · XT CDX · XTANDI · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZIIHERA · ZOLADEX · ZYKADIA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (50%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for hematology & oncology in FL.
Equivalent to $724 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
81
Per 100K population
13.8
County median income
$67,384
Nearest hospital
Adventhealth Zephyrhills
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. McDonough is a mixed practice specialist, with above-average Medicare volume (top 16% in FL), and high industry engagement (speaking/promotional, top 4%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. McDonough experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. McDonough performed 12,240 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. McDonough receive payments from pharmaceutical companies?
Yes. Dr. McDonough received a total of $364,047 from 93 companies across 1,122 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McDonough's costs compare to other hematology & oncologys in Zephyrhills?
Dr. McDonough's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McDonough) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Zephyrhills
Browse hematology & oncologys in Zephyrhills ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in FL
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in FL
Which FL hematology & oncologys receive the most from drug and device companies.
By company
Rigel Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Rigel Pharmaceuticals, Inc..
By company
BeiGene USA, Inc. Payments to Doctors
See all physicians who received payments from BeiGene USA, Inc..
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology